IRCCS Istituto Tumori Giovanni Paolo II, — Bari, BA

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Bari →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of IRCCS Istituto Tumori Giovanni Paolo II,, compiled from the ClinicalTrials.gov public registry.

67

Registered studies

37

Active

22

Recruiting now

10

Completed

4

Stopped or withdrawn

Most-studied conditions

Non Small Cell Lung Cancer · Diffuse Large B-cell Lymphoma · ROS1-positive Non-Small Cell Lung Cancer (NSCLC) · Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Recently updated registry entries

NCT06846671 — A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic… (Recruiting)
NCT05920356 — A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… (Recruiting)
NCT05388669 — A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab… (Active Not Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.